Ladyzhets, B. (2021, November 9). The U.S. Is Relying On Other Countries’ Data To Make Its Booster Shot Decisions. FiveThirtyEight. https://fivethirtyeight.com/features/the-u-s-is-relying-on-other-countries-data-to-make-its-booster-shot-decisions/

Chatterjee, D., Tauzin, A., Marchitto, L., Gong, S. Y., Boutin, M., Bourassa, C., Beaudoin-Bussières, G., Bo, Y., Ding, S., Laumaea, A., Vézina, D., Perreault, J., Gokool, L., Morrisseau, C., Arlotto, P., Fournier, É., Guilbault, A., Delisle, B., Levade, I., … Finzi, A. (2022). SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-weeks interval between doses. Cell Reports, 0(0). https://doi.org/10.1016/j.celrep.2022.110429

Ashish K. Jha, MD, MPH on Twitter. (n.d.). Twitter. Retrieved February 2, 2022, from https://twitter.com/ashishkjha/status/1487868684412628996

Health Nerd. (2022, January 15). It was always likely that immunity to COVID-19 would wane, and we now know the median time to waning is around 1.5-2 years post infection for most people, sometimes less 😕 [Tweet]. @GidMK. https://twitter.com/GidMK/status/1482188340091060229

Colson, P., Delerce, J., Burel, E., Dahan, J., Jouffret, A., Fenollar, F., Yahi, N., Fantini, J., La Scola, B., & Raoult, D. (2021). Emergence in Southern France of a new SARS-CoV-2 variant of probably Cameroonian origin harbouring both substitutions N501Y and E484K in the spike protein [Preprint]. Infectious Diseases (except HIV/AIDS). https://doi.org/10.1101/2021.12.24.21268174

Garcia-Beltran, W. F., Denis, K. J. S., Hoelzemer, A., Lam, E. C., Nitido, A. D., Sheehan, M. L., Berrios, C., Ofoman, O., Chang, C. C., Hauser, B. M., Feldman, J., Gregory, D. J., Poznansky, M. C., Schmidt, A. G., Iafrate, A. J., Naranbhai, V., & Balazs, A. B. (2021). MRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant (p. 2021.12.14.21267755). https://doi.org/10.1101/2021.12.14.21267755

The Lancet Haematology. (2021, November 12). NEW Viewpoint by @Erik_Klok_MD, @MPaiMD, Menno Huisman & @ProfMakris discussing the epidemiology, pathophysiology, and optimal diagnostic and therapeutic management of vaccine-induced immune thrombotic thrombocytopenia #VITT #COVID19Vaccine https://thelancet.com/journals/lanhae/article/PIIS2352-3026(21)00306-9/fulltext https://t.co/9PbjaioA2T [Tweet]. @TheLancetHaem. https://twitter.com/TheLancetHaem/status/1459072729332826123

Hulme, W. J., Williamson, E. J., Green, A., Bhaskaran, K., McDonald, H. I., Rentsch, C. T., Schultze, A., Tazare, J., Curtis, H. J., Walker, A. J., Tomlinson, L., Palmer, T., Horne, E., MacKenna, B., Morton, C. E., Mehrkar, A., Fisher, L., Bacon, S., Evans, D., … Goldacre, B. (2021). Comparative effectiveness of ChAdOx1 versus BNT162b2 COVID-19 vaccines in Health and Social Care workers in England: A cohort study using OpenSAFELY [Preprint]. Epidemiology. https://doi.org/10.1101/2021.10.13.21264937

Kupferschmidt, K., VogelMar. 27, G., 2021, & Am, 10:20. (2021, March 27). A rare clotting disorder may cloud the world’s hopes for AstraZeneca’s COVID-19 vaccine. Science | AAAS. https://www.sciencemag.org/news/2021/03/rare-clotting-disorder-may-cloud-worlds-hopes-astrazenecas-covid-19-vaccine

Pavord, S., Scully, M., Hunt, B. J., Lester, W., Bagot, C., Craven, B., Rampotas, A., Ambler, G., & Makris, M. (2021). Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis. New England Journal of Medicine, NEJMoa2109908. https://doi.org/10.1056/NEJMoa2109908

Ledford, H. (2021, August 24). COVID vaccines and blood clots: What researchers know so far. Nature. https://www.nature.com/articles/d41586-021-02291-2?utm_source=twt_nat&utm_medium=social&utm_campaign=nature

Cobey, Sarah, Daniel B. Larremore, Yonatan H. Grad, and Marc Lipsitch. ‘Concerns about SARS-CoV-2 Evolution Should Not Hold Back Efforts to Expand Vaccination’. Nature Reviews Immunology, 1 April 2021, 1–6. https://doi.org/10.1038/s41577-021-00544-9.